Related Experiment Video
Updated: Aug 15, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
ANCA-negative microscopic polyangiitis with neuromuscular involvement: When pathology could make the difference
Francesca Vitali1, Maria Ausilia Sciarrone1, Giovanni Frisullo1
1Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Neurologia, L.go A. Gemelli 8, Roma, Lazio 00168, Italy.
Microscopic polyangiitis (MPA) can present with muscle weakness and organ dysfunction, even without clear antineutrophil cytoplasmic autoantibodies (ANCA). Early diagnosis and immunosuppressive therapy are crucial for improving patient outcomes in this pauci-immune vasculitis.
Area of Science:
- Nephrology
- Rheumatology
- Neurology
Background:
- Microscopic polyangiitis (MPA) is a pauci-immune small vessel vasculitis often associated with antineutrophil cytoplasmic autoantibodies (ANCA).
- MPA typically presents with diverse organ manifestations, including renal and pulmonary involvement.
Observation:
- A 74-year-old Asian man presented with rapid onset lower limb weakness, renal, and pulmonary dysfunction.
- Antineutrophil cytoplasmic autoantibody (ANCA) levels were borderline throughout the disease course.
- Electrophysiological studies indicated neuromuscular involvement, and biopsies confirmed small vessel vasculitis.
Findings:
- The patient's condition improved significantly after initiating targeted immunosuppressive combination therapy.
- This case highlights a presentation of MPA with neuromuscular symptoms and borderline ANCA levels.
Implications:
- Microscopic polyangiitis should be considered in the differential diagnosis of acute/subacute muscle weakness, particularly when accompanied by organ dysfunction.
- The absence of definitive ANCA detection should not exclude MPA in patients with suggestive clinical and pathological findings.
- This underscores the importance of a comprehensive diagnostic approach for multi-organ diseases like MPA.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction

